Nanomedicine Market New Opportunities For Industry Growth And Forecast To 2025Posted by Neha Bora on September 20th, 2019 San Francisco, 20 September 2019: The Report Nanomedicine Market Analysis By Products, (Therapeutics, Regenerative Medicine, Diagnostics), By Application, (Clinical Oncology, Infectious diseases), By Nanomolecule (Gold, Silver, Iron Oxide, Alumina), & Segment Forecasts, 2018 – 2025 The global nanomedicine market is anticipated to reach USD 350.8 billion by 2025, according to a new report by Grand View Research, Inc. Development of novel nanotechnology-based drugs and therapies is driven by the need to develop therapies that have fewer side effects and that are more cost-effective than traditional therapies, in particular for cancer. Application of nanotechnology-based contrast reagents for diagnosis and monitoring of the effects of drugs on an unprecedented short timescale is also attributive drive growth in the coming years. Additionally, demand for biodegradable implants with longer lifetimes that enable tissue restoration is anticipated to influence demand. As per the WHO factsheet, cancer is found to be one of the major causes of mortality and morbidity worldwide, with approximately 14 million new cases in 2012 and 8.2 million cancer-related deaths. Thus, demand for nanomedicine in order to curb such high incidence rate is expected to boost market progress during the forecast period. Solutions such as nanoformulations with triggered release for tailor-made pharmacokinetics, nanoparticles for local control of tumor in combination with radiotherapy, and functionalized nanoparticles for targeted in-vivo activation of stem cell production are anticipated to drive R&D, consequently resulting in revenue generation in the coming years. Biopharmaceutical and medical devices companies are actively engaged in development of novel products as demonstrated by the increasingly growing partnerships between leading enterprises and nanomedicine startups. For instance, in November 2015, Ablynx and Novo Nordisk signed a global collaboration and a licensing agreement for development and discovery of innovative drugs with multi-specific nanobodies. This strategic partnership is anticipated to rise the net annual sales of the products uplifting the market growth. However, in contrary with the applications of nanotechnology, the entire process of lab to market approval is a tedious and expensive one with stringent regulatory evaluation involved thereby leading investors to remain hesitant for investments. Access Research Report of Nanomedicine Market @ www.grandviewresearch.com/industry-analysis/nanomedicine-market Further key findings from the report suggest:
Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals Grand View Research has segmented the nanomedicine market on the basis of product, application, nanomolecule type, and region: Nanomedicine Product Outlook (Revenue, USD Billion; 2013 - 2025)
Nanomedicine Application Outlook (Revenue, USD Billion; 2013 - 2025)
Nanomedicine Nanomolecule Type Outlook (Revenue, USD Billion; 2013 - 2025)
Nanomedicine Regional Outlook (Revenue, USD Billion; 2013 - 2025)
Access Press Release of Nanomedicine Market @ www.grandviewresearch.com/press-release/global-nanomedicine-market About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Like it? Share it!More by this author |